Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1210/jc.2013-3826 http://scihub22266oqcxt.onion/10.1210/jc.2013-3826 C4037730!4037730 !24517150     free     free     free Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\24517150 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       J+Clin+Endocrinol+Metab 2014 ; 99 (6 ): 1955-69 Nephropedia Template TP {{tp|p=24517150 |t=2014. Acromegaly and McCune-Albright syndrome |pdf=|usr=}}{{24517150 }} gab.com Text Acromegaly and McCune-Albright syndrome JO: J Clin Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=24517150 #FOAvip BACKGROUND: McCune-Albright syndrome (MAS) includes the triad of poly/monostotic fibrous dysplasia, café-au-lait spots, and hyperfunctioning endocrinopathies. Acromegaly affects around 20% of MAS patients. AIMS: The objective was to review all reported cases of acromegaly associated with MAS. METHODS: All studies and case reports of acromegaly in patients with MAS were systematically sought in the world literature up to January 2013. We also included new data (from three unreported cases) and updated data on 23 previously reported patients from our two centers. RESULTS: We reviewed the cases of 112 patients (65 males). Mean age at diagnosis of acromegaly was 24.4 years (range, 3-64). Among the 40 pediatric patients, 23 (57%) had precocious puberty. GH/IGF-1 excess was suggested by accelerated growth in 85% of pediatric cases. Acromegaly was almost always associated with skull base fibrous dysplasia. Modern imaging techniques (computed tomography or magnetic resonance imaging) revealed an adenoma in 54% of the patients (macroadenoma in more than two-thirds). Median GH levels and mean IGF-1 SD score at diagnosis were 57 ?g/L (2.8 to 291 ?g/L) and 8 (2.3 to 24), respectively. Hyperprolactinemia was present in 81% (mean, 149 ?g/L; range, 21-600). Pituitary surgery, performed in 25 cases, very rarely cured the GH/IGF-1 excess. Somatostatin analogs improved GH/IGF-1 levels in most patients but achieved control of acromegaly in only 17 (30%) of 56 patients. Pegvisomant achieved normal IGF-1 levels in 10 of 13 cases. CONCLUSION: Acromegaly, which is present in 20-30% of patients with MAS, raises particular diagnostic and therapeutic issues. Twit Text FOAVip Acromegaly and McCune-Albright syndrome ????J Clin Endocrinol Metab http://www.kidney.de/pget.php?&tw=1&pmid=24517150 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24517150 #FOAvip English Wikipedia <ref>{{Cite pmid|24517150 }}</ref> Acromegaly and McCune-Albright syndrome #MMPMID24517150 Salenave S ; Boyce AM ; Collins MT ; Chanson P J Clin Endocrinol Metab 2014[Jun]; 99 (6 ): 1955-69 PMID24517150 show ga BACKGROUND: McCune-Albright syndrome (MAS) includes the triad of poly/monostotic fibrous dysplasia, café-au-lait spots, and hyperfunctioning endocrinopathies. Acromegaly affects around 20% of MAS patients. AIMS: The objective was to review all reported cases of acromegaly associated with MAS. METHODS: All studies and case reports of acromegaly in patients with MAS were systematically sought in the world literature up to January 2013. We also included new data (from three unreported cases) and updated data on 23 previously reported patients from our two centers. RESULTS: We reviewed the cases of 112 patients (65 males). Mean age at diagnosis of acromegaly was 24.4 years (range, 3-64). Among the 40 pediatric patients, 23 (57%) had precocious puberty. GH/IGF-1 excess was suggested by accelerated growth in 85% of pediatric cases. Acromegaly was almost always associated with skull base fibrous dysplasia. Modern imaging techniques (computed tomography or magnetic resonance imaging) revealed an adenoma in 54% of the patients (macroadenoma in more than two-thirds). Median GH levels and mean IGF-1 SD score at diagnosis were 57 ?g/L (2.8 to 291 ?g/L) and 8 (2.3 to 24), respectively. Hyperprolactinemia was present in 81% (mean, 149 ?g/L; range, 21-600). Pituitary surgery, performed in 25 cases, very rarely cured the GH/IGF-1 excess. Somatostatin analogs improved GH/IGF-1 levels in most patients but achieved control of acromegaly in only 17 (30%) of 56 patients. Pegvisomant achieved normal IGF-1 levels in 10 of 13 cases. CONCLUSION: Acromegaly, which is present in 20-30% of patients with MAS, raises particular diagnostic and therapeutic issues. |Acromegaly/*complications/epidemiology/therapy [MESH] |Adolescent [MESH] |Adult [MESH] |Child [MESH] |Child, Preschool [MESH] |Female [MESH] |Fibrous Dysplasia, Polyostotic/*complications/epidemiology/therapy [MESH] |Humans [MESH] |Male [MESH] |Middle Aged [MESH]Acromegaly and McCune-Albright syndrome (epmc).pdf DeepDyve Pubget Overpricing